CLGN News - Candlesense

CollPlant to Present at the 2025 International Conference on Biofabrication

(NASDAQ:CLGN) REHOVOT, Israel, Sept. 2, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products ...

Announcement

7 days ago

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

REHOVOT, Israel, Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its ...

Conference

15 days ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

- Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire - - Raised $3.6 million in registered direct offering in second quarter - REHOVOT, Israe...

How does CollPlant's Q2 financial performance compare to analyst expectations and to its key competitors in the regenerative biotech sector? What are the intended allocations for the $3.6 million raised in the registered direct offering and how will it affect the company's cash position? How will the appointment of the new U.S.-based commercial executive influence sales momentum for rhCollagen and bioinks?

Earnings

20 days ago